Media
Press Release
10
2022.08
Recbio announces Phase III Clinical Trial Progress Of Recombinant HPV 9-Valent Vaccine
03
2022.08
Approval Of The Comparative Study Between ReCOV And mRNA Vaccines By FDA In The Philippines
27
2022.06
Clinical Trial Approval For mRNA Covid-19 Vaccine For Omicron Variant In The Philippines
02
2022.05
Clinical Trial Approval For ReCOV In The PRC And The Overseas Clinical Trial Progress Of ReCOV
Publications
2023.03.06
Lyophilized mRNA-lipid nanoparticle vaccines with long-term stability and high antigenicity against SARS-CoV-2
Download
2022.05.11
The preliminary safety and immunogenicity results of a randomized, double-blind, placebo-controlled Phase I trial for a recombinant two-component subunit SARS-CoV-2 vaccine ReCOV
2022.02.12
Lyophilized mRNA-lipid nanoparticles vaccine with long-term stability and high antigenicity against SARS-CoV-2
2021.11.09
A trimeric NTD and RBD SARS-CoV-2 subunit vaccine induced protective immunity in CAG-hACE2 transgenic mice and rhesus macaques